
The best Bull and Bear pitches based on recency and number of recommendations.
**Physicians love Epocrates' mobile applications, because they reduce prescription errors, improve patient care, and save time.**Epocrates is disrupting the face-to-face sales model used by pharma companies by offering a more targeted and… More
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about EPOC.
Recs
Undervalued based on assets.
Recs
Huge potential for future revenue, but so far untapped. 2013-2014 things should pick up as they capitalize on their user base of 50% of US physicians, the most valuable customers in the world.
Recs
**Physicians love Epocrates' mobile applications, because they reduce prescription errors, improve patient care, and save time.
**Epocrates is disrupting the face-to-face sales model used by pharma companies by offering a more targeted and cost-effective way to introduce physicians to new and existing drugs.
**The company has ridden its first-mover advantage to an 80% market share that reaches 45% of all U.S. physicians, and it benefits from a recurring revenue base to fund R&D for new products.
Find the members with the highest scoring picks in EPOC.
04redsox (< 20) Score: +233.62
The Score Leader is the player with the highest score across all their picks in EPOC.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
04redsox | < 20 | 4/14/2011 |
![]() |
5Y | $21.79 | -46.17% | +187.45% | +233.62 | 0 Comment | |
![]() |
multicharts | < 20 | 8/29/2012 |
![]() |
5Y | $8.75 | +34.13% | +165.47% | +131.34 | 0 Comment |
modestus1 | < 20 | 9/4/2012 |
![]() |
5Y | $8.88 | +32.09% | +166.38% | -134.28 | 1 Comment | |
jrawk28 | 44.67 | 1/17/2012 |
![]() |
5Y | $8.90 | +31.80% | +188.82% | -157.02 | 1 Comment | |
SMGERMAN100 | 20.89 | 1/8/2013 |
![]() |
5Y | $11.69 | +0.34% | +157.60% | -157.26 | 0 Comment | |
adamsdad123 | < 20 | 1/8/2013 |
![]() |
5Y | $11.68 | +0.43% | +157.84% | -157.41 | 0 Comment | |
retailsails | 98.96 | 9/28/2012 |
![]() |
1Y | $11.67 | +0.51% | +160.74% | -160.23 | 0 Comment | |
Arrico | 91.00 | 10/31/2011 |
![]() |
5Y | $8.71 | +34.67% | +196.25% | -161.57 | 0 Comment | |
super72 | 78.30 | 11/4/2011 |
![]() |
5Y | $8.45 | +38.82% | +201.26% | -162.44 | 0 Comment | |
giantcreek | < 20 | 12/1/2011 |
![]() |
1Y | $8.54 | +37.35% | +200.92% | -163.57 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.